Simethicone

Quick links to important sections

Simethicone

Selected form

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Simethicone

Overview of Simethicone

Simethicone is an oral anti-foaming agent used to manage symptoms associated with excess gas in the digestive tract. It is frequently utilized to provide relief from bloating, flatulence, and abdominal discomfort caused by pressure in the stomach or intestines.

Mechanism of Action

Unlike many other gastrointestinal medications, simethicone does not prevent the formation of gas or interact with the body's biological processes to reduce gas production. Instead, it acts physically on the surface tension of gas bubbles within the GI tract.

  • Breaking Bubble Surface Tension: Simethicone works by changing the surface tension of small gas bubbles trapped in the stomach and intestines.
  • Coalescence: This change allows smaller bubbles to join together, or coalesce, into larger bubbles.
  • Ease of Elimination: These larger bubbles are more easily passed through the body via belching or flatus, thereby relieving the pressure and bloating associated with trapped gas.

Pharmacokinetics

Simethicone is considered physiologically inert. It is not absorbed into the bloodstream through the intestinal wall, nor does it interfere with the absorption of nutrients or other medications. Because it remains within the digestive tract and is excreted unchanged by the body, its action is purely local and mechanical.

What side effects are possible with Simethicone?

Possible Side Effects and Safety Information

Simethicone is classified as a gastrointestinal defoaming agent with a generally limited systemic risk profile, owing to its non-systemic mechanism of action; it is not absorbed into the bloodstream. The officially documented adverse reactions are primarily derived from post-marketing reports, which limits the ability to establish reliable frequency categories, often resulting in the classification of Rare or Not Known.


Documented Adverse Reactions

The most frequently documented, non-serious adverse events generally involve the Gastrointestinal Disorders system, including reports of nausea, constipation, and diarrhea.

The most significant safety concern recognized in regulatory documents is a hypersensitivity or severe allergic reaction to the active ingredient or its excipients. These rare but serious adverse reactions are grouped under the Immune System Disorders and Skin and Subcutaneous Tissue Disorders categories, potentially manifesting as rash, itching (pruritus), and swelling of the face or tongue.


Population-Specific Safety Notes

The regulatory safety profile notes specific considerations for certain patient groups. Due to the negligible systemic exposure of the compound, no adverse effects are anticipated during pregnancy or lactation. Official statements note that Simethicone is not expected to be excreted into breast milk.


Safety Restriction

The only major restriction for use listed in regulatory labeling is a contraindication based on a known allergy or hypersensitivity to Simethicone or any of the inactive ingredients within the formulation.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Simethicone overdose is defined by the drug's physical properties as an inert compound.

Overdose scope Regulatory Information Summary
Documented overdose presentations No specific signs or symptoms of systemic overdose or toxicity are documented in regulatory labeling. This is due to the drug’s non-systemic absorption.
Physiological systems affected No systemic physiological systems are officially listed as affected, consistent with the compound’s inert status.
Emergency-response statements Regulatory labeling requires contacting a healthcare professional or Poison Control Center immediately in the event of accidental over-ingestion.
When immediate medical help is required Urgent medical attention must be sought immediately following any over-ingestion concern, irrespective of the non-toxic profile.

Overdose classifications (high-level) Regulatory Information Summary
Severity classification Overdose is generally classified as non-toxic, as defined in official regulatory documents.
Treatment necessity No specific antidote is known or required.

Official Overdose Statements

  • Regulatory documents confirm that Simethicone does not have documented systemic signs of overdose because it is chemically inert and not absorbed from the gastrointestinal tract.
  • Monitoring of patients is generally deemed unnecessary, and treatment is limited to supportive measures and observation for theoretical over-ingestion.

Connection to the overall overdose profile

The official regulatory documents define the Simethicone overdose profile by its fundamental property of non-systemic absorption, which results in the absence of documented systemic signs. Despite this non-toxic profile, regulatory authorities mandate the immediate instruction to contact emergency services or a poison center for any reported over-ingestion, ensuring professional oversight for all drug exposures.

Therapeutic Uses of Simethicone

Main Uses and Benefits of Simethicone

Simethicone is a surfactant used to manage symptoms associated with the presence of excess gas in the digestive tract. It functions as an anti-foaming agent, targeting the physical properties of gas bubbles rather than altering biological processes or chemical levels in the body.

Relieving Gas-Related Symptoms

The primary use of simethicone is the relief of discomfort caused by trapped gas in the stomach and intestines. By reducing the surface tension of gas bubbles, simethicone allows smaller, trapped bubbles to coalesce into larger ones. This process makes the gas easier to eliminate through natural means, such as belching or flatulence. It is commonly used to address:

  • Abdominal Pressure: Reduces the heavy, tight sensation often felt in the midsection when gas is trapped.
  • Bloating: Helps minimize the physical swelling or distension of the abdomen caused by gas accumulation.
  • Flatulence: Facilitates the passage of gas to reduce internal buildup.

Use in Diagnostic Procedures

Beyond symptomatic relief, simethicone is frequently utilized in clinical settings to improve the clarity of diagnostic imaging. During procedures such as endoscopies or ultrasounds, gas bubbles can obscure the view of the gastrointestinal lining or internal organs. By breaking down these bubbles, simethicone helps provide a clearer visual field for medical professionals.

Benefits of the Mechanism of Action

Simethicone is often selected for its localized action. Because it is not absorbed into the bloodstream, its effects are limited to the digestive tract. This characteristic makes it a common choice for addressing temporary discomfort caused by:

  • Dietary triggers (e.g., high-fiber foods or carbonated beverages).
  • Air swallowed during eating or drinking.
  • Post-operative gas buildup.

Eligibility and Restrictions for Use

Who can and cannot use Simethicone?

Simethicone's eligibility profile is primarily defined by its lack of systemic absorption, allowing for broad use across nearly all populations as documented in official regulatory labeling.

Population Eligibility Scope

Category Official Regulatory Status
Allowed Age Groups Use is established across the entire lifespan, including neonates, infants, children, adolescents, and adults.
Contraindication Patients with known Hypersensitivity to simethicone or any product excipient are absolutely prohibited from use.
Organ Function No specific restrictions or dosage adjustments are documented for patients with hepatic or renal impairment.
Pregnancy/Lactation Use is generally permitted due to non-systemic action; however, over-the-counter labels mandate consultation with a health professional before use.

Eligibility Structure Summary

The most significant restriction is the formal absolute prohibition for individuals with a history of hypersensitivity. All other populations are eligible under standard conditions. Use in infants and neonates is specifically restricted to age-appropriate liquid formulations as defined in the product labeling. Regulatory documents classify the drug as generally safe for all ages, with standard consultation advisory required for pregnancy and breastfeeding.

What should I know about interactions with other medicines?

Simethicone is generally considered to have a low potential for clinically significant drug interactions because it is not absorbed into the bloodstream. It acts locally within the gastrointestinal tract.

However, there is one moderate interaction of note concerning thyroid hormones.

Drug-Drug Interactions

Interacting Medicine Potential Effect of Interaction Clinical Management Consideration
Levothyroxine (and other thyroid products like liothyronine) Simethicone may interfere with the absorption of levothyroxine from the stomach, potentially reducing its effectiveness. If you take levothyroxine for a thyroid condition, take it at least four hours before or after the simethicone product to minimize this effect.

Other Potential Interactions

While evidence is limited, some reports suggest caution when taking simethicone with carbamazepine, as it could potentially increase carbamazepine levels, though this requires further study. Additionally, simethicone is often combined with other ingredients like antacids (aluminum hydroxide, magnesium hydroxide). Always review the ingredients of any combination product and consult a healthcare professional regarding all other prescription, over-the-counter, herbal remedies, and dietary supplements being used.

Mechanism of Action

Simethicone's mechanism of action is physical-chemical and localized, distinguishing it from systemically absorbed agents. It is pharmacologically inert and non-systemic, meaning it does not interact with biological entities such as receptors, enzymes, or ion channels, nor is it absorbed into the bloodstream. The drug’s functional "target" is the gas-liquid interface of small, foamy gas bubbles trapped within the gastrointestinal (GI) lumen.

Simethicone acts as a surfactant, initiating a physical cascade by infiltrating and drastically lowering the surface tension of the mucous film stabilizing the foam. This reduction causes the bubble walls to destabilize and rupture. The resulting free gas then undergoes coalescence, merging into fewer, larger pockets. This mechanical reorganization increases the mobility of the gas, moving it from a trapped state to a form that is more readily propelled through the GI tract. This mechanism is restricted entirely to the GI lumen and does not influence the metabolic or microbial processes responsible for the actual rate of gas production.

Dosage and Administration Information

Administration Guidelines

Simethicone is a non-systemic antiflatulent exclusively administered by the oral route. Instructions require the medicine to be used on an as-needed (PRN) basis, generally following a divided-use schedule up to four times daily. All dosing and administration instructions must strictly adhere to recommended limits.


Dosage and Frequency

Population Standard Single Dose Maximum Daily Dose (24 hours) Timing
Adults (ge 12 years) 40 mg to 250 mg 500 mg After meals and at bedtime
Children (2 to 12 years) 40 mg 480 mg After meals and at bedtime
Infants (under 2 years) 20 mg 240 mg After meals and at bedtime

Administration Instructions by Form

Form-specific directions ensure proper use:

  • Chewable Tablets: Must be chewed thoroughly before swallowing to allow the medicine to act completely within the gastrointestinal tract.
  • Capsules and Regular Tablets: Should be swallowed whole with water. They are not intended to be crushed or chewed.
  • Oral Suspension (Drops): The bottle must be shaken well before each use. The dose should be measured using the dedicated dropper and may be mixed with a small volume of cool water or infant formula to ease administration.

The medication is intended for intermittent and short-term use for symptomatic relief. The stated maximum daily limits must not be exceeded unless expressly advised and supervised by a physician.

Recent Clinical Evidence

Evidence for Use in Acute Gas Symptoms (Bloating, Pressure, and Fullness)

Research has explored how this agent is evaluated in studies that track symptom changes over time, focusing on patient-reported assessments of discomfort. These trials typically involved adults experiencing episodic gas-related discomfort. Findings describe symptom patterns observed in studies where participants tracked their experiences, and research reported changes in symptom severity measured during the study period. However, when the agent was studied for conditions characterized by fluctuating manifestations, such as certain irritable bowel syndrome symptoms, findings were mixed across various studies.

Research Landscape in Gastrointestinal Diagnostic Procedures

This agent was evaluated in a significant number of Randomized Controlled Trials (RCTs) for its use in preparation for diagnostic procedures like endoscopy and colonoscopy. Studies explored its use to clear bubbles and foam that can obscure the lining of the digestive tract. Outcomes monitored by researchers included the quality of mucosal visualization and the duration of the procedure. Studies observed that the addition of the agent was associated with differences in mucosal cleanliness scores when compared to control groups in many trials.

Evidence in Combination Products and Areas of Uncertainty

The agent was also studied for gas symptoms when combined with other active ingredients used for acute diarrhea; these trials report that the combination product data show patterns related to a reduced time measurement to complete relief of gas-related symptoms when compared to the single ingredients. The research base in special populations, such as infants experiencing colic, is inconsistent. Furthermore, data for certain groups remain insufficient, and long-term effects are not fully established, as most research exploring symptom changes had limited follow-up durations.

Key Studies & References

  1. FDA Final Rule for OTC Antiflatulent Drug Products (1996 Monograph)
  2. NIH StatPearls: Simethicone (Clinical Overview)

Frequently Asked Questions (FAQ)

Common questions about Simethicone (FAQ)

Q: Can Simethicone interact with common pain relievers like ibuprofen?

A: Official information does not specifically list an interaction with common pain relievers such as ibuprofen. The drug generally has a low potential for causing clinically significant drug interactions. This is due to its physical-chemical action, which means the medicine is not absorbed into the bloodstream.

Q: Is it okay for a person with kidney disease to use Simethicone?

A: Official drug labeling does not document any specific restrictions or dosage adjustments for individuals with renal (kidney) impairment. The non-systemic nature of the drug generally permits broad use. However, some combination products advise consulting a healthcare professional before use.

Q: Can Simethicone cause constipation or diarrhea?

A: The official safety information notes that Simethicone has documented adverse reactions that affect the gastrointestinal system. These reported effects include constipation and diarrhea. Other non-serious events, such as nausea, have also been documented.

Q: What are the most commonly reported side effects of Simethicone?

A: According to post-marketing reports compiled by regulators, the most frequently documented non-serious adverse events involve the gastrointestinal system. These effects primarily include reports of nausea, constipation, and diarrhea.

Q: Can Simethicone interact with vitamins or mineral supplements?

A: Official documents generally advise consulting a healthcare professional regarding all dietary supplements being used, including vitamins and minerals. While Simethicone is not systemically absorbed, this is standard guidance to ensure all products are reviewed.

Q: Do I need to take Simethicone with food, or can I take it on an empty stomach?

A: Official administration instructions generally describe taking the medicine as needed after meals and at bedtime. This timing is typically associated with addressing the presence of gas built up during the digestive process.

Q: What should I do if I miss a dose of Simethicone?

A: Simethicone is an as-needed medication taken only for symptomatic relief. Regulatory guidance suggests that if a dose is missed, you may take it as soon as possible. However, if it is almost time for your next scheduled dose, the guidance generally describes skipping the missed one and returning to the usual dosing schedule.

Q: What does Simethicone do to the gas inside the intestines?

A: Simethicone works by acting as a surfactant, which means it reduces the surface tension of the mucous film surrounding the small gas bubbles trapped in the digestive tract. This physical action causes the small bubbles to coalesce, or merge, into larger gas pockets that are readily eliminated from the body.

Q: Is Simethicone the same thing as activated charcoal?

A: Official regulatory documents classify Simethicone as a synthetic antiflatulent agent. Its action is physical, working by reducing the surface tension of gas bubbles in the gastrointestinal tract. Activated charcoal, in contrast, works by absorbing gas and toxins.

Q: Why is Simethicone in so many different over-the-counter products?

A: Official information notes that Simethicone is a widely recognized and available over-the-counter antiflatulent. It is often included in combination products, given its non-systemic mechanism of action.

Q: Is there a limit on how long you can take Simethicone?

A: The drug is intended for intermittent and short-term use solely for symptomatic relief. While the labeling for some combination products advises against using the maximum dosage for more than two weeks, the drug's use is limited to intermittent and short-term periods.

Q: What happens if I accidentally take too much Simethicone at once?

A: The regulatory labeling for the medicine contains a clear warning to seek immediate medical help or contact a Poison Control Center in the event of an accidental overdose. This warning highlights the importance of prompt attention for any potential safety issues.

Q: Does Simethicone help with trapped gas pain, or just general bloating?

A: Simethicone is officially labeled for the relief of symptoms commonly referred to as gas discomfort. This includes feelings of upper gastrointestinal pressure, fullness, and bloating. Its physical mechanism facilitates the passage of gas through the digestive tract.

Q: Why do doctors use Simethicone during certain medical procedures?

A: Simethicone has been studied for use in preparation for certain gastrointestinal diagnostic procedures, such as endoscopy. Studies observed that the addition of the agent was associated with differences in mucosal cleanliness scores when compared to control groups.

Q: Does taking Simethicone make you pass more gas?

A: The physical action of Simethicone is intended to help gas move from a trapped, foamy state into larger, free pockets. This process is associated with the expulsion of gas, making it easier for the body to eliminate the gas through natural means, such as burping or flatulence.

Q: Can Simethicone affect the results of an endoscopy or other medical test?

A: Regulatory research describes the use of Simethicone in preparation for diagnostic procedures like endoscopy. It is used specifically to disperse foam and bubbles, which helps improve the quality of mucosal visualization.

Q: Why do some people say Simethicone doesn't work for them?

A: Official summaries of research note that the relationship between gas accumulation and the symptoms patients report as gas discomfort is not always clear. When Simethicone was studied for conditions with fluctuating symptoms, findings have been mixed across various clinical trials.

Q: How does Simethicone differ from bismuth subsalicylate (Pepto-Bismol)?

A: Simethicone is officially classified as a non-systemic antiflatulent agent that acts physically to reduce the surface tension of gas bubbles. Bismuth subsalicylate is classified as an antidiarrheal agent. This latter drug works by decreasing fluid flow into the bowel and reducing inflammation.

Q: Is Simethicone recommended for irritable bowel syndrome (IBS) symptoms?

A: The research findings for Simethicone in conditions with fluctuating manifestations, such as certain IBS symptoms, have been described as mixed across various studies. The evidence base for this use is not entirely consistent.

Q: What kind of gas/bloating does Simethicone actually help with?

A: The drug is labeled for the relief of symptoms commonly referred to as excess gas. This includes the feelings of pressure, fullness, and general bloating in the gastrointestinal tract.

Q: Is Simethicone considered a 'natural' remedy or a chemical drug?

A: Simethicone is an over-the-counter medicine classified as a synthetic compound, not a natural remedy. Its active ingredient is a blend of a silicone polymer and silica gel.

Q: Do studies support the use of Simethicone in infants for colic?

A: Regulatory documents note that the research base for Simethicone in special populations, such as infants experiencing colic, is officially noted as inconsistent.

Q: What is the official purpose of Simethicone according to regulators?

A: The official purpose of the medicine is defined in regulatory documents as an antiflatulent agent. It is also classified as a gastrointestinal defoaming agent based on its physical mechanism of action.

Q: Does Simethicone change the chemical composition of the gas bubbles?

A: Simethicone's mechanism is purely physical-chemical and localized entirely within the gut. Official information states that it does not influence the metabolic or microbial processes responsible for the actual rate or chemical composition of the gas being produced.

Q: Are there any food or drink restrictions while using Simethicone?

A: Official regulatory labeling does not contain any specific warnings or restrictions regarding food or drink when using Simethicone. The medicine is typically used after meals and at bedtime.

Q: Can Simethicone be used to help with gas after surgery?

A: Official information indicates that Simethicone has been used as an adjunct in the symptomatic treatment of gas pains occurring after surgical procedures.

Q: Does Simethicone help reduce burping?

A: Simethicone is labeled to relieve the symptoms of excessive gas, including burping and flatulence. The drug's physical action facilitates the elimination of gas that is trapped in the stomach and intestines.

Q: Can Simethicone interact with herbal remedies or teas?

A: Official labeling advises consulting a healthcare professional about all herbal remedies being used. This caution applies to all other prescription and over-the-counter medicines as well.

Q: Is the research evidence for Simethicone considered high quality?

A: Research has explored the agent across a variety of settings, from improving visualization during diagnostic procedures to tracking symptom changes. Different themes of evidence have been reported depending on the specific use being studied.

Q: Is Simethicone generally considered non-habit forming?

A: The compound is classified in regulatory resources as physiologically inactive and non-systemic. This means that the medicine is not absorbed into the bloodstream.

Q: What is the primary substance Simethicone helps to eliminate from the body?

A: The primary substance Simethicone helps to eliminate is excess gas trapped in the gastrointestinal tract. Its role is to reorganize the trapped, foamy gas pockets to facilitate their elimination.

Q: Are there different forms of Simethicone, like liquid versus capsules?

A: Simethicone is manufactured for oral administration and is available in several dosage forms. These preparations include oral capsules, liquid oral suspension, chewable tablets, and specialized pediatric drops.

How should Simethicone be stored and disposed of?

How to Store and Dispose of Simethicone

Simethicone must be stored at controlled room temperature, typically between 20 C and 25 C (68 F and 77 F). The medication must be protected from light, heat, and moisture, and excessive heat above 40 C (104 F) must be avoided. Liquid formulations, such as oral suspensions and drops, must not be frozen.

All simethicone products must be kept in their closed container and stored out of the reach of children. The product should not be used if the safety seal or any individual blister unit is broken. Expired or unused medicine must be disposed of according to local regulations; generally, it should not be flushed down a toilet or poured into a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Simethicone found in:

A-Z Index: